Help us improve the FORRT website

Acute Myeloid Leukemia

 

Open Access Target Validation Is a More Efficient Way to Accelerate Drug Discovery

There is a scarcity of novel treatments to address many unmet medical needs. Industry and academia are finally coming to terms with the fact that the prevalent models and incentives for innovation in early stage drug discovery are failing to promote …

Help us improve the FORRT website

We would be grateful if you could complete this survey. Your feedback will directly inform improvements to navigation, accessibility, and content structure.
Note:All answers are anonymous and will help us make the website better for everyone!

Take the Survey